Cormorant Asset Management, LP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 221 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$2,230,000
-34.2%
194,274
-2.9%
0.18%
-17.7%
Q3 2018$3,390,000
-37.5%
200,000
-47.7%
0.22%
-45.3%
Q2 2018$5,427,000
-25.3%
382,1920.0%0.40%
-25.7%
Q1 2018$7,262,000
+10.7%
382,192
-4.5%
0.54%
-21.3%
Q4 2017$6,560,000
+9.3%
400,0000.0%0.69%
-35.1%
Q3 2017$6,000,000
+70.5%
400,0000.0%1.06%
+81.6%
Q2 2017$3,520,000
+12.8%
400,000
-33.3%
0.58%
+28.7%
Q1 2017$3,120,000
+57.3%
600,000
-7.7%
0.45%
+69.7%
Q4 2016$1,983,000
-69.5%
650,000
-53.6%
0.27%
-62.7%
Q3 2016$6,493,000
-20.0%
1,402,3310.0%0.72%
-37.8%
Q2 2016$8,119,000
+298.8%
1,402,331
+288.5%
1.15%
+254.2%
Q3 2015$2,036,000
-49.1%
361,0000.0%0.32%
-38.9%
Q2 2015$4,003,000
-42.2%
361,000
-18.3%
0.53%
-50.3%
Q1 2015$6,931,000
-8.9%
442,000
-11.6%
1.07%
-8.7%
Q4 2014$7,605,000
+41.0%
500,0000.0%1.17%
+5.8%
Q3 2014$5,393,000
-29.4%
500,0000.0%1.11%
-45.2%
Q2 2014$7,635,000
-29.6%
500,000
-16.7%
2.02%
-18.9%
Q1 2014$10,848,000
+369.8%
600,000
+261.0%
2.49%
+272.2%
Q4 2013$2,309,000166,2000.67%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders